(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLD, CRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






124 Result: FDA

FDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease

November 18th, 2026

Silver Spring, MD / CRWE PRESS RELEASE / November 18, 2026 -  The U.S. Food and Drug Administration today approved Infilbray (venglustat) tablets, the first treatment for the neurological symptoms of Type 3 Gaucher disease (GD3) in adults and pe. Read more

FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longer

November 18th, 2026

New therapy offers a meaningful treatment option for families facing a rare and serious childhood disease Silver Spring, MD / CRWE PRESS RELEASE / November 17, 2026 - The U.S. Food and Drug Administration today approved Lembaz (adrabetadex) inject. Read more

FDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma

November 05th, 2026

Silver Spring, MD / CRWE PRESS RELEASE / November 5, 2026 - The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic hea. Read more

FDA Approves First Plasmid DNA-based Immunotherapy for Adults with Recurrent Respiratory Papillomatosis

October 30th, 2026

Groundbreaking therapy provides additional treatment option that fights the disease at its source, not only its symptoms Silver Spring, MD / CRWE PRESS RELEASE / October 30, 2026 -  The U.S. Food and Drug Administration today granted accelera. Read more

FDA Launches New Program to Advance Neuroscience Medical Product Development

October 22nd, 2026

Neuroscience Advancement and Innovation Nexus to coordinate agency action on brain and nervous system conditions, with inaugural focus on Alzheimer's prevention Silver Spring, MD / CRWE PRESS RELEASE / October 22, 2026 -  The U.S. Food a. Read more

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment

October 21st, 2026

New treatment may allow some patients to maintain viral control after stopping all hepatitis B therapy Silver Spring, MD / CRWE PRESS RELEASE / October 20, 2026 - The U.S. Food and Drug Administration today approved Hibsago (bepirovirsen) inj. Read more

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

October 20th, 2026

Silver Spring, MD / CRWE PRESS RELEASE / October 20, 2026 - The U.S. Food and Drug Administration yesterday approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hor. Read more

FDA Approves Immunotherapy That May Allow Certain Patients with Rectal Cancer to Avoid Chemotherapy, Radiation and Surgery

October 19th, 2026

Silver Spring, MD / CRWE PRESS RELEASE / October 19, 2026 -  The U.S. Food and Drug Administration today granted accelerated approval for a new use of the immunotherapy Jemperli (dostarlimab-gxly) that may allow some patients with locally advanc. Read more

FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer

October 14th, 2026

Expanded approval of Anktiva marks a new FDA approach to using evidence across closely related forms of bladder cancer Silver Spring, MD / CRWE PRESS RELEASE / October 14, 2026 - The U.S. Food and Drug Administration today expanded the approved us. Read more

FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme

September 29th, 2026

Silver Spring, MD / CRWE PRESS RELEASE / September 29, 2026 - The U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, . Read more

FDA Grants Accelerated Approval to a New Breast Cancer Treatment

September 04th, 2026

Silver Spring, MD / CRWE PRESS RELEASE / September 04, 2026 - The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innov. Read more

FDA Approves First Drug to Treat Alexander Disease

September 03rd, 2026

New therapy is the first to directly target the underlying cause of this rare neurological disease Silver Spring, MD / CRWE PRESS RELEASE / September 03, 2026 - The U.S. Food and Drug Administration has approved Zanvastro (zilganersen) i. Read more

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

August 27th, 2026

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease. Silver Spring, MD / CRWE PRESS RELEASE / August 27, 2026 - The U.S. Food and Drug Administration . Read more

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

August 26th, 2026

Silver Spring, MD / CRWE PRESS RELEASE / August 26, 2026 - The U.S. Food and Drug Administration today approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to pat. Read more

FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar

August 25th, 2026

New device can help people with diabetes detect warning signs of a dangerous complication before it becomes a medical emergency Silver Spring, MD / CRWE PRESS RELEASE / August 25, 2026 - The U.S. Food and Drug Administration today authorized . Read more

Load More Content